Source:http://linkedlifedata.com/resource/pubmed/id/21349409
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2011-2-25
|
pubmed:abstractText |
In this article, updated analyses of the National Cancer Institute Surveillance, Epidemiology and End Results (SEER) registry (1973-2007) are presented and compared with epidemiologic GEP-NET data from Europe and Asia. Several studies have demonstrated a steadily increasing incidence of GEP-NETs, and this escalation is still ongoing (SEER data 2004-2007). The common primary GEP-NET sites exhibit unique epidemiologic profiles with distinct patterns of incidence, age at diagnosis, stage, and survival. Overall, GEP-NET survival has improved over the past 3 decades, although the outcome for poorly differentiated tumors remains dismal.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1558-4410
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-18, vii
|
pubmed:meshHeading |
pubmed-meshheading:21349409-Gastrointestinal Neoplasms,
pubmed-meshheading:21349409-Humans,
pubmed-meshheading:21349409-Incidence,
pubmed-meshheading:21349409-Neuroendocrine Tumors,
pubmed-meshheading:21349409-Pancreatic Neoplasms,
pubmed-meshheading:21349409-SEER Program,
pubmed-meshheading:21349409-Time Factors,
pubmed-meshheading:21349409-United States
|
pubmed:year |
2011
|
pubmed:articleTitle |
The epidemiology of gastroenteropancreatic neuroendocrine tumors.
|
pubmed:affiliation |
Gastrointestinal Pathobiology Research Group, Department of Surgery, Yale University School of Medicine, 310 Cedar Street, PO Box 208602, New Haven, CT 06520-8062, USA.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|